United States· US:16571-856_06c53ec5-f3d9-47e2-943e-631ed695adcc

Pentoxifylline

A pentoxifylline product containing pentoxifylline, registered in United States by Rising Pharma Holdings, Inc.. The same ATC class is registered in 12 of our 19 countries.

ATC C04AD03US label

Checked against FDA National Drug Code directory (United States) on June 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pentoxifyllineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pentoxifylline is registered in 12 of 19 countries.

Countries holding a registration under ATC C04AD03 (pentoxifylline), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
7 of them publish a price we can compare per daily dose

Search pentoxifylline products by name

Pentoxifylline · ATC C04AD03

12 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Netherlands
Norwayprice
Polandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: PENTOXIFYLLINE
Manufacturer: Rising Pharma Holdings, Inc.
Country: United States (US)
ATC code: C04AD03
ATC class: Pentoxifylline
Defined daily dose: 1 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: June 26, 2026

Packs & prices · 6

ndc11
1657185601
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-01)
ndc11
1657185650
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-856-50)
ndc11
1657185690
1 BLISTER PACK in 1 CARTON (16571-856-90) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
ndc11
16571-856-01
ndc11
16571-856-50
ndc11
16571-856-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

435 interactions on record for pentoxifylline.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pentoxifylline against other medicines How interaction checks work

Pentoxifylline · interactions on record

435 records

4 severe
252 moderate
179 info

Most severe, free to view

CimetidineA02BA01moderate
PapaverineA03AD01moderate
Obeticholic acidA05AA04moderate
MannitolA06AD16moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pentoxifylline in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentoxifylline products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Pentomer Retard, Pentoxi Retard
Belgium · Torental
Bulgaria · Агапурин, Агапурин Sr
Cyprus · Angiopent Retard, Tarοntal
Czechia · Agapurin, Pentomer Retard
Germany · Pentoxifyllin 1 A Pharma, Pentoxifyllin Ratiopharm
Estonia · Pentilin, Vasonit Retard
Spain · Elorgan, Hemovás
France · Pentoxifylline Lp Biogaran, Pentoxifylline Lp Eg
United Kingdom (Northern Ireland) · Pentoxifylline Neuraxpharm Uk
Greece · Tarontal
Croatia · Pentilin, Trental
Hungary · Chinotal, Pentoxyl
Italy · Trental
Lithuania · Agapurin, Pentilin
Luxembourg · Pentoxifylline Ratiopharm, Torental
Latvia · Pentilin, Polfilin
Netherlands · Trental
Norway · Trental
Poland · Agapurin, Agapurin Sr
Portugal · Pentoxifilina Generis, Trental
Romania · Angiopent Retard, Pentoxi Retard
Slovenia · Pentilin
Slovakia · Agapurin, Agapurin Sr

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f28ed1fb-00f8-4544-8276-1ce08110bc97
GET /v1/drugs/f28ed1fb-00f8-4544-8276-1ce08110bc97?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "400",
  "substance": "PENTOXIFYLLINE",
  "productndc": "16571-856",
  "dosage_form": "TABLET, EXTENDED RELEASE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA074425",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about pentoxifylline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console